Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep

SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received clearance fro... Diagnostics, FDAQuidel, AmpliVue, Streptococcus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news